The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study.
 
Ranju Gupta
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
Stock and Other Ownership Interests - Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Abbvie; Abbvie; Abbvie; Abbvie
Consulting or Advisory Role - Deciphera; Deciphera; Deciphera; Deciphera; Okava Pharmaceuticals; Okava Pharmaceuticals; Okava Pharmaceuticals; Okava Pharmaceuticals; Tactical Therapeutics; Tactical Therapeutics; Tactical Therapeutics; Tactical Therapeutics; TYME; TYME; TYME; TYME
 
Susan Halabi
Employment - ASCO; ASCO; ASCO; ASCO
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Ferring; Ferring; Ferring; Ferring
 
Pam K. Mangat
No Relationships to Disclose
 
Stacy D. D'Andre
No Relationships to Disclose
 
Eyal Meiri
Employment - Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America (I); Cancer Treament Centers of America (I); Cancer Treament Centers of America (I); Cancer Treament Centers of America (I)
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen
 
Sagun Shrestha
No Relationships to Disclose
 
Sasha L. Warren
No Relationships to Disclose
 
Shamika Ranasinghe
No Relationships to Disclose
 
Richard L. Schilsky
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems